C12N 2760/14141
Use of virus, viral particle or viral elements as a vector
C12N2760/14141 (Use of virus, viral particle or viral elements as a vector) appears on 5 US grants and 12 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 12
- Assignees
- 9
- Inventors
- 19
- Latest grant
- 1 Oct 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 2 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
| 2018 | 0 | 2 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 2 |
By publication year.
Subgroups
Granted patents
- C12N 2760/14145Special targeting system for viral vectorsIndexing code5
- C12N 2760/14143Viral genome or elements thereof as genetic vectorIndexing code4
- C12N 2760/14142Virus or viral particle as vehicleIndexing code0
- C12N 2760/14144Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code0
Recent patents
- Human ebola virus species and compositions and methods thereof1 Oct 2019US 10,428,314 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Human Ebola virus species and compositions and methods thereof17 Oct 2017US 9,790,473 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Filovirus vectors and noninfectious filovirus-based particles2 Dec 2014US 8,900,595 B2Wisconsin Alumni Research Foundation
- Generation of virus-like particles and use as panfilovirus vaccine23 Mar 2010US 7,682,618 B2The United States of America as represented by the Secretary of the Army
- Filovirus vectors and noninfectious filovirus-based particles1 May 2007US 7,211,378 B2Wisconsin Alumni Research Foundation
- Gene therapies for stargardt disease (abca4)27 Jun 2024US 2024/0207450 A1University of Massachusetts
- Scaffolds For Inducing Antibody Responses Against Antigenic Sites23 May 2024US 2024/0166696 A1Emory University
- Filovirus vectors and particles produced therefrom27 Sep 2018US 2018/0273588 A1Wisconsin Alumni Research Foundation (WARF)
- Human ebola virus species and compositions and methods thereof4 Jan 2018US 2018/0002675 A1The United States of America, as represented by the Secretary, Department of Health and Human Serv
- Human ebola virus species and compositions and methods thereof6 Aug 2015US 2015/0218525 A1The United States of America, as represented by the Secretary, Department of Health and Human Serv
Most cited
By later US patents
- Generation of virus-like particles and use as panfilovirus vaccine20US 7,682,618 B2The United States of America as represented by the Secretary of the Army · 2010
- Filovirus vectors and noninfectious filovirus-based particles17US 7,211,378 B2Wisconsin Alumni Research Foundation · 2007
- Filovirus vectors and noninfectious filovirus-based particles16US 8,900,595 B2Wisconsin Alumni Research Foundation · 2014
- Human ebola virus species and compositions and methods thereof1US 10,428,314 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2019
- Human Ebola virus species and compositions and methods thereof1US 9,790,473 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2017